Anne Bol

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Do quality of life and work productivity change in early axial spondyloarthritis and non-axial spondyloarthritis patients after 2 years?

Do quality of life and work productivity change in early axial spondyloarthritis and non-axial spondyloarthritis patients after 2 years?

Journal: Rheumatology (Oxford, England)

Published: April 04, 2024

Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials.

Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials.

Journal: Seminars in arthritis and rheumatism

Published: September 18, 2023

Instrument selection for the ASAS core outcome set for axial spondyloarthritis.

Instrument selection for the ASAS core outcome set for axial spondyloarthritis.

Journal: Annals of the rheumatic diseases

Published: May 03, 2022

Geographical prevalence of family history in patients with axial spondyloarthritis and its association with HLA-B27 in the ASAS-PerSpA study.

Geographical prevalence of family history in patients with axial spondyloarthritis and its association with HLA-B27 in the ASAS-PerSpA study.

Journal: RMD open

Published: December 22, 2021

Test-retest reliability of outcome measures: data from three trials in radiographic and non-radiographic axial spondyloarthritis.

Test-retest reliability of outcome measures: data from three trials in radiographic and non-radiographic axial spondyloarthritis.

Journal: RMD open

Published: July 22, 2021

Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey.

Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey.

Journal: The Journal of rheumatology

Published: July 14, 2021

Age at onset in axial spondyloarthritis around the world: data from the Assessment in SpondyloArthritis international Society Peripheral Involvement in Spondyloarthritis study.

Age at onset in axial spondyloarthritis around the world: data from the Assessment in SpondyloArthritis international Society Peripheral Involvement in Spondyloarthritis study.

Journal: Rheumatology (Oxford, England)

Published: April 06, 2021

New insight in understanding the contribution of SGLT1 in cardiac glucose uptake: evidence for a truncated form in mice and humans.

New insight in understanding the contribution of SGLT1 in cardiac glucose uptake: evidence for a truncated form in mice and humans.

Journal: American journal of physiology. Heart and circulatory physiology

Published: January 08, 2021

Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach.

Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach.

Journal: Seminars in arthritis and rheumatism

Published: November 26, 2020

Two different invitation approaches for consecutive rounds of a Delphi survey led to comparable final outcome.

Two different invitation approaches for consecutive rounds of a Delphi survey led to comparable final outcome.

Journal: Journal of clinical epidemiology

Published: March 31, 2020

Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts.

Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts.

Journal: Annals of the rheumatic diseases

Published: May 13, 2019

2'-deoxy-2'-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck.

2'-deoxy-2'-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck.

Journal: Oncotarget

Published: January 19, 2018

Showing 1-12 of 37

Last Updated: 09/26/2026